{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:33:41Z","timestamp":1787027621681,"version":"build-2736575974"},"reference-count":122,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>It is important for clinicians to consider exposure to toxic substances and nutritional deficiencies when diagnosing and managing cases of vision loss. In these cases, physiologic damage can alter the function of key components of the visual pathway before morphologic changes can be detected by traditional imaging methods. Electrophysiologic tests can aid in the early detection of such functional changes to visual pathway components, including the retina or optic nerve. This review provides an overview of various electrophysiologic techniques, including multifocal electroretinogram (mfERG), full-field ERG (ffERG), electrooculogram (EOG), pattern electroretinogram (PERG), and visual evoked potential (VEP) in monitoring the retinal and optic nerve toxicities of alcohol, amiodarone, cefuroxime, cisplatin, deferoxamine, digoxin, ethambutol, hydroxychloroquine, isotretinoin, ocular siderosis, pentosane, PDE5 inhibitors, phenothiazines (chlorpromazine and thioridazine), quinine, tamoxifen, topiramate, vigabatrin, and vitamin A deficiency.<\/jats:p>","DOI":"10.3390\/biom12101390","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:03:10Z","timestamp":1664485390000},"page":"1390","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of Visual Electrophysiology to Monitor Retinal and Optic Nerve Toxicity"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-135X","authenticated-orcid":false,"given":"Tsun-Kang","family":"Chiang","sequence":"first","affiliation":[{"name":"University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH 44101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla Marie","family":"White","sequence":"additional","affiliation":[{"name":"University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH 44101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree K.","family":"Kurup","sequence":"additional","affiliation":[{"name":"University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH 44101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3115-8930","authenticated-orcid":false,"given":"Minzhong","family":"Yu","sequence":"additional","affiliation":[{"name":"University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH 44101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"ref_1","first-page":"260","article-title":"Alcohol and the Eye","volume":"16","author":"Karimi","year":"2021","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3341\/kjo.2011.25.2.146","article-title":"A case of optic nerve atrophy with severe disc cupping after methanol poisoning","volume":"25","author":"Shin","year":"2011","journal-title":"Korean J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/OPX.0b013e31823ee128","article-title":"Methanol poisoning: Ocular and neurological manifestations","volume":"89","author":"Sharma","year":"2012","journal-title":"Optom. Vis. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"912883","DOI":"10.3389\/fncir.2022.912883","article-title":"Comprehensive visual electrophysiological measurements discover crucial changes caused by alcohol addiction in humans: Clinical values in early prevention of alcoholic vision decline","volume":"16","author":"Xie","year":"2022","journal-title":"Front. Neural Circuits"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4087096","DOI":"10.1155\/2016\/4087096","article-title":"The Intoxication Effects of Methanol and Formic Acid on Rat Retina Function","volume":"2016","author":"Liu","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.13075\/ijomeh.1896.00452","article-title":"Visual evoked potentials in patients after methanol poisoning","volume":"29","author":"Urban","year":"2016","journal-title":"Int. J. Occup. Med. Environ. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0039-6257(87)90028-2","article-title":"Ocular involvement in the fetal alcohol syndrome","volume":"31","author":"Stromland","year":"1987","journal-title":"Surv. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1067\/mpa.2000.105278","article-title":"Clinical and electroretinographic findings in fetal alcohol syndrome","volume":"4","author":"Hug","year":"2000","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Dahl","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/11532320-000000000-00000","article-title":"Amiodarone: Review of pulmonary effects and toxicity","volume":"33","author":"Papiris","year":"2010","journal-title":"Drug Saf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0039-6257(97)00118-5","article-title":"Ocular side effects of amiodarone","volume":"42","author":"Mantyjarvi","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00006982-200306000-00011","article-title":"Retinal evaluation of patients on chronic amiodarone therapy","volume":"23","author":"Shaikh","year":"2003","journal-title":"Retina"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101343","DOI":"10.1016\/j.ajoc.2022.101343","article-title":"High dose cefuroxime causing retinal toxicity in a patient undergoing trabeculectomy","volume":"25","author":"Ku","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcrs.2010.08.047","article-title":"Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery","volume":"37","author":"Delyfer","year":"2011","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jcrs.2011.03.032","article-title":"Macular infarction after inadvertent intracameral cefuroxime","volume":"37","author":"Qureshi","year":"2011","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_16","first-page":"571","article-title":"Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery","volume":"96","author":"Jaumandreu","year":"2021","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10633-014-9465-7","article-title":"Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery","volume":"130","author":"Faure","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(00)00522-5","article-title":"Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy","volume":"130","author":"Wang","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/1078155218759805","article-title":"Cilioretinal artery occlusion associated with cisplatin","volume":"25","author":"Alkan","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1997.tb00280.x","article-title":"Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy","volume":"96","author":"Caraceni","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ajo.2005.07.046","article-title":"Retinal ischemia with neovascularization in cisplatin related retinal toxicity","volume":"141","author":"Kwan","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/15569527.2013.879877","article-title":"The protective effect of selenium in cisplatin-related retinotoxicity","volume":"33","author":"Yazici","year":"2014","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00432-017-2384-8","article-title":"Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer","volume":"143","author":"Dulz","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archneur.1992.00530250087021","article-title":"Intra-arterial cisplatin--associated optic and otic toxicity","volume":"49","author":"Maiese","year":"1992","journal-title":"Arch. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<310::AID-MPO12>3.0.CO;2-G","article-title":"Retinal toxicity associated with cisplatin and etoposide in pediatric patients","volume":"28","author":"Hilliard","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0161-6420(85)34036-8","article-title":"Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas","volume":"92","author":"Miller","year":"1985","journal-title":"Ophthalmology"},{"key":"ref_27","first-page":"249617","article-title":"Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature","volume":"2015","author":"Barteselli","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","article-title":"The expanded clinical spectrum of deferoxamine retinopathy","volume":"109","author":"Haimovici","year":"2002","journal-title":"Ophthalmology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","article-title":"Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy","volume":"91","author":"Lakhanpal","year":"1984","journal-title":"Ophthalmology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","article-title":"Ocular toxicity of high-dose intravenous desferrioxamine","volume":"2","author":"Davies","year":"1983","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00417-017-3650-9","article-title":"Electrophysiological assessment for early detection of retinal dysfunction in beta-thalassemia major patients","volume":"255","author":"Dettoraki","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","article-title":"Ocular changes in patients undergoing long-term desferrioxamine treatment","volume":"68","author":"Arden","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0168-5597(87)90035-9","article-title":"Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: Longitudinal studies","volume":"68","author":"Taylor","year":"1987","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.braindev.2005.03.006","article-title":"Neurophysiologic and intellectual evaluation of beta-thalassemia patients","volume":"28","author":"Economou","year":"2006","journal-title":"Brain Dev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Renard, D., Rubli, E., Voide, N., Borruat, F.X., and Rothuizen, L.E. (2015). Spectrum of digoxin-induced ocular toxicity: A case report and literature review. BMC Res. Notes, 8.","DOI":"10.1186\/s13104-015-1367-6"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjo.86.11.1259","article-title":"Acquired colour vision deficiency in patients receiving digoxin maintenance therapy","volume":"86","author":"Lawrenson","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_37","first-page":"275","article-title":"Digoxin toxicity. Recognizing the varied visual presentations","volume":"13","author":"Piltz","year":"1993","journal-title":"J. Clin. Neuroophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-123-9-199511010-00006","article-title":"Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations","volume":"123","author":"Butler","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archopht.1981.03930020442007","article-title":"Digoxin retinal toxicity. Clinical and electrophysiological evaluation of a cone dysfunction syndrome","volume":"99","author":"Weleber","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31818e3c6b","article-title":"Incidence and clinical features of ethambutol-induced optic neuropathy in Korea","volume":"28","author":"Lee","year":"2008","journal-title":"J. Neuroophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.kjms.2015.05.004","article-title":"Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan","volume":"31","author":"Chen","year":"2015","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08820530701457134","article-title":"Ethambutol neuroretinopathy","volume":"22","author":"Vistamehr","year":"2007","journal-title":"Semin. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02150448","article-title":"Clinical ERG findings in ethambutol intoxication","volume":"218","author":"Hennekes","year":"1982","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00006324-198409000-00007","article-title":"Visual electrophysiology and psychophysics in chronic alcoholics and in patients on tuberculostatic chemotherapy","volume":"61","author":"Williams","year":"1984","journal-title":"Am. J. Optom. Physiol. Opt."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00143950","article-title":"Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy","volume":"67","author":"Kakisu","year":"1987","journal-title":"Doc. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/eye.2008.361","article-title":"Multifocal electroretinography changes in patients on ethambutol therapy","volume":"23","author":"Lai","year":"2009","journal-title":"Eye"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjo.2004.065656","article-title":"Multifocal ERG in ethambutol associated visual loss","volume":"89","author":"Behbehani","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.2004.058099","article-title":"Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy","volume":"89","author":"Lai","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_49","first-page":"630","article-title":"Ethambutol retinal toxicity: An electrophysiologic study","volume":"99","author":"Yen","year":"2000","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0168-5597(88)90073-1","article-title":"Serial pattern evoked potential recording in a case of toxic optic neuropathy due to ethambutol","volume":"71","author":"Petrera","year":"1988","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.41683","article-title":"American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity","volume":"73","author":"Rosenbaum","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf","year":"2017","journal-title":"Eye"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ophtha.2015.02.011","article-title":"Hydroxychloroquine and chloroquine retinopathy: A systematic review evaluating the multifocal electroretinogram as a screening test","volume":"122","author":"Tsang","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.122.7.973","article-title":"Multifocal electroretinographic evaluation of long-term hydroxychloroquine users","volume":"122","author":"Maturi","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcjo.2019.05.013","article-title":"Effect of stopping hydroxychloroquine therapy on the multifocal electroretinogram in patients with rheumatic disorders","volume":"55","author":"Adamptey","year":"2020","journal-title":"Can. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1097\/IAE.0b013e318181445b","article-title":"A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine","volume":"28","author":"Chang","year":"2008","journal-title":"Retina"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1444-0938.2010.00476.x","article-title":"Retina in rheumatic diseases: Standard full field and multifocal electroretinography in hydroxychloroquine retinal dysfunction","volume":"94","author":"Nebbioso","year":"2011","journal-title":"Clin. Exp. Optom."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10792-011-9456-6","article-title":"A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine","volume":"31","author":"Heravian","year":"2011","journal-title":"Int. Ophthalmol."},{"key":"ref_59","first-page":"S3","article-title":"The use of isotretinoin in the treatment of acne vulgaris: Clinical considerations and future directions","volume":"7","author":"Leyden","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1986.01050180065031","article-title":"Abnormal retinal function associated with isotretinoin therapy for acne","volume":"104","author":"Weleber","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajd.12107","article-title":"Isotretinoin and night blindness","volume":"55","author":"Teo","year":"2014","journal-title":"Australas J. Dermatol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjo.73.4.286","article-title":"Visual toxicity of synthetic retinoids","volume":"73","author":"Brown","year":"1989","journal-title":"Br. J. Ophthalmol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bjo.2006.092833","article-title":"Does use of isotretinoin rule out a career in flying?","volume":"90","author":"Mollan","year":"2006","journal-title":"Br. J. Ophthalmol"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/eye.1993.83","article-title":"Ocular siderosis","volume":"7","author":"Mahon","year":"1993","journal-title":"Eye"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00142682","article-title":"A long term follow up of ocular siderosis: Quantitative assessment of the electroretinogram","volume":"76","author":"Schechner","year":"1990","journal-title":"Doc. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000027520","article-title":"Electroretinographic assessment of early changes in ocular siderosis","volume":"214","author":"Imaizumi","year":"2000","journal-title":"Ophthalmologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/23258160-20201223-04","article-title":"New Insights Into Pentosan Polysulfate Maculopathy","volume":"52","author":"Davis","year":"2021","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1442-9071.2009.02070.x","article-title":"Phosphodiesterase inhibitors and the eye","volume":"37","author":"Kerr","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-9394(01)01052-2","article-title":"Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram","volume":"132","author":"Luu","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(98)05473-7","article-title":"Retinal side-effects of sildenafil","volume":"353","author":"Vobig","year":"1999","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"Tamminga","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"ref_74","first-page":"53","article-title":"Dopamine antagonism by thioridazine in schizophrenia","volume":"10","author":"Meltzer","year":"1975","journal-title":"Biol. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","article-title":"Ocular adverse effects of common psychotropic agents: A review","volume":"24","author":"Richa","year":"2010","journal-title":"CNS Drugs"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01224623","article-title":"The effects of dopamine blockade on the human flash electroretinogram","volume":"86","author":"Holopigian","year":"1994","journal-title":"Doc. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archopht.1978.03910060006002","article-title":"Progressive chorioretinopathy after receiving thioridazine","volume":"96","author":"Meredith","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0168-5597(90)90054-H","article-title":"Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects","volume":"77","author":"Bartel","year":"1990","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0006-3223(98)00379-5","article-title":"Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: A pilot study","volume":"45","author":"Warner","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000118502","article-title":"Effects of single doses of diazepam, chlorpromazine, imipramine and trihexyphenidyl on visual-evoked potentials","volume":"20","author":"Bartel","year":"1988","journal-title":"Neuropsychobiology"},{"key":"ref_81","first-page":"151","article-title":"Possible indication of dopaminergic blockade in man by electroretinography","volume":"13","author":"Filip","year":"1978","journal-title":"Int. Pharm."},{"key":"ref_82","first-page":"253","article-title":"Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children","volume":"10","author":"Saletu","year":"1975","journal-title":"Biol. Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.survophthal.2007.10.010","article-title":"The negative ERG: Clinical phenotypes and disease mechanisms of inner retinal dysfunction","volume":"53","author":"Audo","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/OPX.0b013e31815ed769","article-title":"Clinical electrophysiology in quinine induced retinal toxicity","volume":"85","author":"Verdon","year":"2008","journal-title":"Optom. Vis. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WNO.0000000000000865","article-title":"Toxic Optic Neuropathy From Quinine Overdose","volume":"40","author":"Freund","year":"2020","journal-title":"J. Neuroophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"bcr0420114166","DOI":"10.1136\/bcr.04.2011.4166","article-title":"Relatively spared central multifocal electroretinogram responses in acute quinine toxicity","volume":"2011","author":"Saeed","year":"2011","journal-title":"BMJ Case Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9394(80)90015-X","article-title":"Abnormalities of the pupil and visual-evoked potential in quinine amblyopia","volume":"89","author":"Gangitano","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.72.1.23","article-title":"Ocular quinine toxicity","volume":"72","author":"Canning","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.survophthal.2021.05.007","article-title":"Retinal toxicities of systemic anticancer drugs","volume":"67","author":"Arora","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"ref_90","first-page":"Doc07","article-title":"Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography","volume":"1","author":"Caramoy","year":"2011","journal-title":"GMS Ophthalmol. Cases"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02713680701229638","article-title":"Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use","volume":"32","author":"Salomao","year":"2007","journal-title":"Curr. Eye Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-009-9203-8","article-title":"Retinal function in patients treated with tamoxifen","volume":"120","author":"Watanabe","year":"2010","journal-title":"Doc. Ophthalmol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.304.6825.495","article-title":"Tamoxifen retinopathy: A rare but serious complication","volume":"304","author":"Bentley","year":"1992","journal-title":"BMJ"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bjo.65.3.177","article-title":"Tamoxifen retinopathy","volume":"65","author":"McKeown","year":"1981","journal-title":"Br. J. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pdpdt.2016.10.004","article-title":"The optical imaging and clinical features of tamoxifen associated macular hole: A case report and review of the literatures","volume":"17","author":"Hu","year":"2017","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_96","first-page":"NC01-04","article-title":"Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache","volume":"10","author":"Hesami","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OPTH.S27695","article-title":"Topiramate and the vision: A systematic review","volume":"6","author":"Abtahi","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajoc.2017.05.005","article-title":"Topiramate-induced macular neurosensory retinal detachment","volume":"7","author":"Rosenberg","year":"2017","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10633-007-9084-7","article-title":"Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy","volume":"116","author":"Tsui","year":"2008","journal-title":"Doc. Ophthalmol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10633-006-9027-8","article-title":"Retinal function and histopathology in rabbits treated with Topiramate","volume":"113","author":"Kjellstrom","year":"2006","journal-title":"Doc. Ophthalmol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"De Luca, C., Gori, S., Mazzucchi, S., Dini, E., Cafalli, M., Siciliano, G., Papa, M., and Baldacci, F. (2021). Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040769"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(97)00086-7","article-title":"Vigabatrin enhances promoted release of GABA in neonatal rat optic nerve","volume":"29","author":"Yee","year":"1998","journal-title":"Epilepsy Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42466-022-00168-x","article-title":"Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol","volume":"4","author":"Maciel","year":"2022","journal-title":"Neurol. Res. Pract."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WNO.0000000000000609","article-title":"Vigabatrin: Lessons Learned From the United States Experience","volume":"38","author":"Foroozan","year":"2018","journal-title":"J. Neuroophthalmol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0404.2011.01596.x","article-title":"Mechanism of action of vigabatrin: Correcting misperceptions","volume":"124","year":"2011","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-0404.2012.01684.x","article-title":"Vigabatrin-associated retinal damage: Potential biochemical mechanisms","volume":"126","author":"Heim","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1159\/000453143","article-title":"The Vigabatrin Induced Retinal Toxicity is Associated with Photopic Exposure and Taurine Deficiency: An In Vivo Study","volume":"40","author":"Tao","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pediatrneurol.2016.09.016","article-title":"mTOR Inhibition Mitigates Molecular and Biochemical Alterations of Vigabatrin-Induced Visual Field Toxicity in Mice","volume":"66","author":"Vogel","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Yang, J., Naumann, M.C., Tsai, Y.T., Tosi, J., Erol, D., Lin, C.S., Davis, R.J., and Tsang, S.H. (2012). Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043889"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","article-title":"Symptomatic and asymptomatic visual loss in patients taking vigabatrin","volume":"106","author":"Daneshvar","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0404.2011.01600.x","article-title":"Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin","volume":"124","author":"Sergott","year":"2011","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2012.05.009","article-title":"Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals","volume":"119","author":"Clayton","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/B:DOOP.0000005338.51554.e3","article-title":"Longitudinal changes in photopic OPs occurring with vigabatrin treatment","volume":"107","author":"Morong","year":"2003","journal-title":"Doc. Ophthalmol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.WNL.0000098938.80082.25","article-title":"Peripheral retinal dysfunction in patients taking vigabatrin","volume":"61","author":"McDonagh","year":"2003","journal-title":"Neurology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3928\/01913913-20110118-01","article-title":"Electrophysiological evaluation of retinal function in children receiving vigabatrin medication","volume":"48","author":"Kjellstrom","year":"2011","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10633-012-9320-7","article-title":"Electroretinographic (ERG) responses in pediatric patients using vigabatrin","volume":"124","author":"Moskowitz","year":"2012","journal-title":"Doc. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1528-1157.2000.tb00117.x","article-title":"Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction","volume":"41","author":"Harding","year":"2000","journal-title":"Epilepsia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jn\/138.10.1835","article-title":"Vitamin a deficiency and clinical disease: An historical overview","volume":"138","author":"Sommer","year":"2008","journal-title":"J. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.eye.6702212","article-title":"Functional observations in vitamin A deficiency: Diagnosis and time course of recovery","volume":"21","author":"McBain","year":"2007","journal-title":"Eye"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10633-009-9200-y","article-title":"Fundus white spots and acquired night blindness due to vitamin A deficiency","volume":"119","author":"Genead","year":"2009","journal-title":"Doc. Ophthalmol."},{"key":"ref_121","first-page":"66","article-title":"The eye signs of vitamin A deficiency","volume":"26","author":"Gilbert","year":"2013","journal-title":"Community Eye Health"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-016-9533-2","article-title":"Treatment of vitamin A deficiency retinopathy with sublingual vitamin A palmitate","volume":"132","author":"Singer","year":"2016","journal-title":"Doc. Ophthalmol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:41:42Z","timestamp":1760143302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":122,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biom12101390"],"URL":"https:\/\/doi.org\/10.3390\/biom12101390","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}